Is COVID-19 less severe in CML patients than in those with other haematological cancers? | Br J Haematol;196(3): 471-472, 2022 02. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

Is COVID-19 less severe in CML patients than in those with other haematological cancers?

Claudiani, Simone.

Claudiani S; Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK.

Br J Haematol ; 196(3): 471-472, 2022 02.

Article in English | MEDLINE | ID: covidwho-1488183

Subject(s)

COVID-19; Hematologic Neoplasms; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Humans; SARS-CoV-2

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Hematologic Neoplasms / COVID-19 Limits: Humans Language: English Journal: Br J Haematol Year: 2022 Document Type: Article Affiliation country: Bjh.17927

Similar

MEDLINE

LILACS

LIS

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Hematologic Neoplasms / COVID-19 Limits: Humans Language: English Journal: Br J Haematol Year: 2022 Document Type: Article Affiliation country: Bjh.17927